Pacific Biosciences of California Inc. buy Stephens
Start price
14.12.23
/
50%
€8.42
Target price
14.12.24
€10.05
Performance (%)
-80.42%
Price
14.06.24
€1.65
Summary
This prediction is currently active. The BUY prediction by Stephens for Pacific Biosciences of California Inc. is performing very badly with a performance of -80.42%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Stephens at any time. Stephens has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | -11.183% | -11.183% |
iShares Core DAX® | -2.926% | -4.228% |
iShares Nasdaq 100 | 4.462% | 8.605% |
iShares Nikkei 225® | 0.306% | 0.284% |
iShares S&P 500 | 2.488% | 4.773% |
Comments by Stephens for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at Stephens. They set an "overweight" rating and a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat